Radiomics in prostate cancer: An up-to-date review
M Ferro, O de Cobelli, G Musi… - Therapeutic …, 2022 - journals.sagepub.com
Prostate cancer (PCa) is the most common worldwide diagnosed malignancy in male
population. The diagnosis, the identification of aggressive disease, and the post-treatment …
population. The diagnosis, the identification of aggressive disease, and the post-treatment …
PI-RADS committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review
IG Schoots, JO Barentsz… - American Journal of …, 2021 - Am Roentgen Ray Soc
The steadily increasing demand for diagnostic prostate MRI has led to concerns regarding
the lack of access to and the availability of qualified MRI scanners and sufficiently …
the lack of access to and the availability of qualified MRI scanners and sufficiently …
[HTML][HTML] Biomarkers in prostate cancer diagnosis: from current knowledge to the role of metabolomics and exosomes
Early detection of prostate cancer (PC) is largely carried out using assessment of prostate-
specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies …
specific antigen (PSA) level; yet it cannot reliably discriminate between benign pathologies …
[HTML][HTML] Diagnostic performance of prostate-specific membrane antigen positron emission tomography–targeted biopsy for detection of clinically significant prostate …
Context Prostate-specific membrane antigen positron emission tomography (PSMA-PET)
has gained acceptance as a staging tool for prostate cancer (PCa). Recent reports suggest …
has gained acceptance as a staging tool for prostate cancer (PCa). Recent reports suggest …
[HTML][HTML] SelectMDx and multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy: a prospective assessment in a multi …
Simple Summary Prostate-specific antigen and digital rectal examination, used to guide
prostate biopsy, often result in overdiagnosis of indolent prostate cancer (PCa) while …
prostate biopsy, often result in overdiagnosis of indolent prostate cancer (PCa) while …
Combined use of prostate-specific antigen density and magnetic resonance imaging for prostate biopsy decision planning: a retrospective multi-institutional study …
Background Previous studies suggested that prostate-specific antigen (PSA) density (PSAd)
combined with magnetic resonance imaging (MRI) may help avoid unnecessary prostate …
combined with magnetic resonance imaging (MRI) may help avoid unnecessary prostate …
Multi‐institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI‐RADS 3 lesions
AM Fang, LA Shumaker, KD Martin, JC Jackson… - Cancer, 2022 - Wiley Online Library
Background Most Prostate Imaging–Reporting and Data System (PI‐RADS) 3 lesions do not
contain clinically significant prostate cancer (CSPCa; grade group≥ 2). This study was …
contain clinically significant prostate cancer (CSPCa; grade group≥ 2). This study was …
[HTML][HTML] Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to reconsider scoring categorization?
E Messina, M Pecoraro, L Laschena, M Bicchetti… - European …, 2023 - Springer
Objectives To evaluate MRI diagnostic performance in detecting clinically significant
prostate cancer (csPCa) in peripheral-zone PI-RADS 4 lesions, comparing those with clearly …
prostate cancer (csPCa) in peripheral-zone PI-RADS 4 lesions, comparing those with clearly …
Magnetic Resonance Imaging, Clinical, and Biopsy Findings in Suspected Prostate Cancer: A Systematic Review and Meta-Analysis
A Haj-Mirzaian, KS Burk, R Lacson, DI Glazer… - JAMA Network …, 2024 - jamanetwork.com
Importance Multiple strategies integrating magnetic resonance imaging (MRI) and clinical
data have been proposed to determine the need for a prostate biopsy in men with suspected …
data have been proposed to determine the need for a prostate biopsy in men with suspected …
Utility of machine learning of apparent diffusion coefficient (ADC) and T2-weighted (T2W) radiomic features in PI-RADS version 2.1 category 3 lesions to predict …
Purpose To evaluate if machine learning (ML) of radiomic features extracted from apparent
diffusion coefficient (ADC) and T2-weighted (T2W) MRI can predict prostate cancer (PCa) …
diffusion coefficient (ADC) and T2-weighted (T2W) MRI can predict prostate cancer (PCa) …